BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen LY, Liu X, Wang SL, Qin CY. Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. J Int Med Res. 2010;38:498-510. [PMID: 20515564 DOI: 10.1177/147323001003800213] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Carloni V, Luong TV, Rombouts K. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever. Liver Int. 2014;34:834-843. [PMID: 24397349 DOI: 10.1111/liv.12465] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 11.0] [Reference Citation Analysis]
2 El Behery MM, Seksaka MA, Ibrahiem MA, Saleh HS, El Alfy Y. Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer. Arch Gynecol Obstet 2013;288:1371-6. [PMID: 23708323 DOI: 10.1007/s00404-013-2863-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
3 Celik ZE, Demir F, Yonar H, Ugras S. Association of endocan expression with clinicopathological prognostic parameters in breast carcinoma. Cancer Biomark 2021. [PMID: 34151832 DOI: 10.3233/CBM-201026] [Reference Citation Analysis]
4 Emet S, Elitok A, Onur I, Kocaaga M, Bilge AK, Oflaz H, Umman B, Oncul A, Bugra Z, Adalet K, Mercanoglu F. Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion. J Thromb Thrombolysis 2017;43:60-7. [PMID: 27638814 DOI: 10.1007/s11239-016-1424-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
5 Yang J, Yang Q, Yu S, Zhang X. Endocan: A new marker for cancer and a target for cancer therapy. Biomed Rep 2015;3:279-83. [PMID: 26137222 DOI: 10.3892/br.2015.438] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
6 Yang J, Sheng S, Yang Q, Li L, Qin S, Yu S, Zhang X. Endocan silencing induces programmed cell death in hepatocarcinoma. Oncol Lett 2017;14:5333-9. [PMID: 29113167 DOI: 10.3892/ol.2017.6857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
7 Xu L, Tang L, Zhang L. Proteoglycans as miscommunication biomarkers for cancer diagnosis. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Elsevier; 2019. pp. 59-92. [DOI: 10.1016/bs.pmbts.2018.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
8 Bender O, Gunduz M, Cigdem S, Hatipoglu OF, Acar M, Kaya M, Grenman R, Gunduz E, Ugur KS. Functional analysis of ESM1 by siRNA knockdown in primary and metastatic head and neck cancer cells. J Oral Pathol Med 2018;47:40-7. [PMID: 29024069 DOI: 10.1111/jop.12648] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
9 Delehedde M, Devenyns L, Maurage CA, Vivès RR. Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol. 2013;2013:705027. [PMID: 23606845 DOI: 10.1155/2013/705027] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
10 Kiliç R, Kurt A, Tad M, Taşdemir S. Endocan Overexpression in Pterygium. Cornea 2017;36:696-9. [PMID: 28410547 DOI: 10.1097/ICO.0000000000001183] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Akarsu M, Atalay HA, Canat L, Ozcan M, Arman Y, Aydın S, Cil E, Kutlu O, Tükek T. Endocan is markedly overexpressed in severe erectile dysfunction. Andrologia 2018;50:e12912. [DOI: 10.1111/and.12912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Huang X, Chen C, Wang X, Zhang JY, Ren BH, Ma DW, Xia L, Xu XY, Xu L. Prognostic value of endocan expression in cancers: evidence from meta-analysis. Onco Targets Ther 2016;9:6297-304. [PMID: 27785077 DOI: 10.2147/OTT.S110295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Medetalibeyoglu A, Emet S, Kose M, Akpinar TS, Senkal N, Catma Y, Kaytaz AM, Genc S, Omer B, Tukek T. Serum Endocan Levels on Admission Are Associated With Worse Clinical Outcomes in COVID-19 Patients: A Pilot Study. Angiology 2021;72:187-93. [PMID: 32969233 DOI: 10.1177/0003319720961267] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
14 Zhang S, Zuo L, Zhou Q, Gui S, Shi R, Wu Q, Wei W, Wang Y. Expression and distribution of endocan in human tissues. Biotechnic & Histochemistry 2012;87:172-8. [DOI: 10.3109/10520295.2011.577754] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
15 Hentschke MR, Lucas LS, Mistry HD, Pinheiro da Costa BE, Poli-de-figueiredo CE. Endocan-1 concentrations in maternal and fetal plasma and placentae in pre-eclampsia in the third trimester of pregnancy. Cytokine 2015;74:152-6. [DOI: 10.1016/j.cyto.2015.04.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
16 Palmiere C, Augsburger M. Endocan measurement for the postmortem diagnosis of sepsis. Legal Medicine 2014;16:1-7. [DOI: 10.1016/j.legalmed.2013.09.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
17 Chang Y, Niu W, Lian PL, Wang XQ, Meng ZX, Liu Y, Zhao R. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer. World J Gastroenterol 2016; 22(23): 5422-5429 [PMID: 27340359 DOI: 10.3748/wjg.v22.i23.5422] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
18 Zhao L, Dai C, Gong Q. Changes of Endocan and its effect on hepatic stem cells during the rapid proliferation process of residual liver after ALPPS procedure. Cell Biochem Funct 2020;38:817-25. [PMID: 32515027 DOI: 10.1002/cbf.3553] [Reference Citation Analysis]
19 Wu X, Wu Y, He L, Wu L, Wang X, Liu Z. Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer. J Cancer 2018;9:2510-7. [PMID: 30026849 DOI: 10.7150/jca.25324] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 18.0] [Reference Citation Analysis]
20 Chen X, Yao Y, Yuan F, Xie B. Overexpression of miR-181a-5p inhibits retinal neovascularization through endocan and the ERK1/2 signaling pathway. J Cell Physiol 2020;235:9323-35. [PMID: 32346884 DOI: 10.1002/jcp.29733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Rocha SF, Schiller M, Jing D, Li H, Butz S, Vestweber D, Biljes D, Drexler HC, Nieminen-kelhä M, Vajkoczy P, Adams S, Benedito R, Adams RH. Esm1 Modulates Endothelial Tip Cell Behavior and Vascular Permeability by Enhancing VEGF Bioavailability. Circ Res 2014;115:581-90. [DOI: 10.1161/circresaha.115.304718] [Cited by in Crossref: 86] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
22 Frahm KA, Nash CP, Tobet SA. Endocan immunoreactivity in the mouse brain: method for identifying nonfunctional blood vessels. J Immunol Methods 2013;398-399:27-32. [PMID: 24055127 DOI: 10.1016/j.jim.2013.09.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
23 Palmiere C, Augsburger M. Markers for sepsis diagnosis in the forensic setting: state of the art. Croat Med J 2014;55:103-14. [PMID: 24778096 DOI: 10.3325/cmj.2014.55.103] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
24 López-Vega JM, Álvarez I, Antón A, Illarramendi JJ, Llombart A, Boni V, García-Velloso MJ, Martí-Climent JM, Pina L, García-Foncillas J. Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer. Cancers (Basel) 2021;13:3511. [PMID: 34298725 DOI: 10.3390/cancers13143511] [Reference Citation Analysis]
25 Zhang S, Zuo L, Gui S, Zhou Q, Wei W, Wang Y. Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin. Mol Biol Rep 2012;39:2843-9. [PMID: 21678055 DOI: 10.1007/s11033-011-1043-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
26 Seo K, Kitazawa T, Yoshino Y, Koga I, Ota Y. Characteristics of serum endocan levels in infection. PLoS One 2015;10:e0123358. [PMID: 25894539 DOI: 10.1371/journal.pone.0123358] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
27 Abu El-asrar AM, Nawaz MI, De Hertogh G, Al-kharashi AS, Van den Eynde K, Mohammad G, Geboes K. The Angiogenic Biomarker Endocan is Upregulated in Proliferative Diabetic Retinopathy and Correlates with Vascular Endothelial Growth Factor. Current Eye Research 2014;40:321-31. [DOI: 10.3109/02713683.2014.921312] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
28 Ozaki K, Toshikuni N, George J, Minato T, Matsue Y, Arisawa T, Tsutsumi M. Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma. J Cancer. 2014;5:221-230. [PMID: 24665346 DOI: 10.7150/jca.7691] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
29 Wang S, Wu Z, Wei L, Zhang J. Endothelial cell-specific molecule-1 as an invasiveness marker for pituitary null cell adenoma. BMC Endocr Disord 2019;19:90. [PMID: 31455321 DOI: 10.1186/s12902-019-0418-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Whayne TF. Endocan in Hypertension and Cardiovascular Disease. Angiology 2014;65:757-9. [DOI: 10.1177/0003319713514478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 Yassine H, De Freitas Caires N, Depontieu F, Scherpereel A, Awad A, Tsicopoulos A, Leboeuf C, Janin A, Duez C, Grigoriu B, Lassalle P. The non glycanated endocan polypeptide slows tumor growth by inducing stromal inflammatory reaction. Oncotarget 2015;6:2725-35. [PMID: 25575808 DOI: 10.18632/oncotarget.2614] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
32 Kim KH, Lee HH, Yoon YE, Na JC, Kim SY, Cho YI, Hong SJ, Han WK. Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma. Oncotarget 2018;9:662-7. [PMID: 29416643 DOI: 10.18632/oncotarget.23087] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
33 Xu H, Chen X, Huang Z. Identification of ESM1 overexpressed in head and neck squamous cell carcinoma. Cancer Cell Int 2019;19:118. [PMID: 31073279 DOI: 10.1186/s12935-019-0833-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
34 Güzel A, Duran L, Köksal N, Torun AC, Alaçam H, Ekiz BC, Murat N. Evaluation of serum endothelial cell specific molecule-1 (endocan) levels as a biomarker in patients with pulmonary thromboembolism. Blood Coagul Fibrinolysis 2014;25:272-6. [PMID: 24509328 DOI: 10.1097/MBC.0000000000000071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
35 Karabakan M, Bozkurt A, Akdemir S, Gunay M, Keskin E. Significance of serum endothelial cell specific molecule-1 (Endocan) level in patients with erectile dysfunction: a pilot study. Int J Impot Res 2017;29:175-8. [PMID: 28424502 DOI: 10.1038/ijir.2017.19] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
36 Kechagia M, Papassotiriou I, Gourgoulianis KI. Endocan and the respiratory system: a review. Int J Chron Obstruct Pulmon Dis 2016;11:3179-87. [PMID: 28003744 DOI: 10.2147/COPD.S118692] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
37 Ziol M, Sutton A, Calderaro J, Barget N, Aout M, Leroy V, Blanc J, Sturm N, Bioulac-sage P, Nahon P, Nault J, Charnaux N, N’kontchou G, Trinchet J, Delehedde M, Seror O, Beaugrand M, Vicaut E, Ganne-carrié N. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma. Journal of Hepatology 2013;59:1264-70. [DOI: 10.1016/j.jhep.2013.07.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
38 Rathnasamy G, Sivakumar V, Foulds WS, Ling EA, Kaur C. Vascular changes in the developing rat retina in response to hypoxia. Exp Eye Res 2015;130:73-86. [PMID: 25433125 DOI: 10.1016/j.exer.2014.11.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
39 Xing Y, Wang Y, Wang S, Wang X, Fan D, Zhou D, An J. Human cytomegalovirus infection contributes to glioma disease progression via upregulating endocan expression. Transl Res 2016;177:113-26. [PMID: 27474433 DOI: 10.1016/j.trsl.2016.06.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
40 Zhao H, Xue Y, Guo Y, Sun Y, Liu D, Wang X. Inhibition of endocan attenuates monocrotaline-induced connective tissue disease related pulmonary arterial hypertension. Int Immunopharmacol 2017;42:115-21. [PMID: 27912147 DOI: 10.1016/j.intimp.2016.11.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
41 Cornelius A, Cortet-Rudelli C, Assaker R, Kerdraon O, Gevaert MH, Prévot V, Lassalle P, Trouillas J, Delehedde M, Maurage CA. Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma. Brain Pathol. 2012;22:757-764. [PMID: 22353248 DOI: 10.1111/j.1750-3639.2012.00578.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
42 Cakir U, Tayman C, Yucel C, Ozdemir O. Can IL-33 and Endocan be New Markers for Retinopathy of Prematurity? Comb Chem High Throughput Screen 2019;22:41-8. [PMID: 30914019 DOI: 10.2174/1386207322666190325120244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Kose M, Emet S, Akpinar TS, Kocaaga M, Cakmak R, Akarsu M, Yuruyen G, Arman Y, Tukek T. Serum Endocan Level and the Severity of Coronary Artery Disease: A Pilot Study. Angiology 2015;66:727-31. [DOI: 10.1177/0003319714548870] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
44 Miao Y, Zong M, Jiang T, Yuan X, Guan S, Wang Y, Zhou D. A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion. Pituitary 2016;19:194-201. [PMID: 26809958 DOI: 10.1007/s11102-015-0698-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
45 Wahb AMSE, El Kassas M, Khamis AK, Elhelbawy M, Elhelbawy N, Habieb MSE. Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol 2021; 13(11): 1753-1765 [PMID: 34904043 DOI: 10.4254/wjh.v13.i11.1753] [Reference Citation Analysis]
46 Bingol Z, Kose M, Pıhtılı A, Akpınar T, Tukek T, Kıyan E. Serum endothelial cell specific molecule-1 (endocan) levels in patients with obstructive sleep apnea. Biomarkers in Medicine 2016;10:177-84. [DOI: 10.2217/bmm.15.117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
47 Bessa J, Albino-Teixeira A, Reina-Couto M, Sousa T. Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases. Clin Chim Acta 2020;509:310-35. [PMID: 32710940 DOI: 10.1016/j.cca.2020.07.041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Pan KF, Yang YC, Lee WJ, Hua KT, Chien MH. Proteoglycan Endocan: A multifaceted therapeutic target in Cancer. Biochim Biophys Acta Rev Cancer 2021;1877:188672. [PMID: 34953930 DOI: 10.1016/j.bbcan.2021.188672] [Reference Citation Analysis]
49 Yoon KH, Kim SY, Moon YS, Roh D, Lee SK, Kim DH. The Relationship between Serum Endocan Levels and Depression in Alzheimer's Disease. Dis Markers 2016;2016:8254675. [PMID: 26924874 DOI: 10.1155/2016/8254675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
50 Wang G, Yu Y, Wang YZ, Wang JJ, Guan R, Sun Y, Shi F, Gao J, Fu XL. Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy. J Cell Physiol 2019;234:17023-49. [PMID: 30888065 DOI: 10.1002/jcp.28436] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 11.7] [Reference Citation Analysis]
51 Zuo L, Lu M, Zhou Q, Wei W, Wang Y. Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway. Food and Chemical Toxicology 2013;62:892-900. [DOI: 10.1016/j.fct.2013.10.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
52 Zhao W, Sun M, Li S, Wang Y, Liu J. Biological and clinical implications of endocan in gastric cancer. Tumour Biol 2014;35:10043-9. [PMID: 25012244 DOI: 10.1007/s13277-014-2287-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]